TRUFF (Rhelion Life Sciences) Gross Profit: $1.16 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rhelion Life Sciences Gross Profit?

Rhelion Life Sciences TRUFF +20.24% Gross Profit is $1.16 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Rhelion Life Sciences's gross profit for the three months ended in Mar. 2026 was $0.34 Mil. Rhelion Life Sciences's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $1.16 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Rhelion Life Sciences's gross profit for the three months ended in Mar. 2026 was $0.34 Mil. Rhelion Life Sciences's Revenue for the three months ended in Mar. 2026 was $0.64 Mil. Therefore, Rhelion Life Sciences's Gross Margin % for the quarter that ended in Mar. 2026 was 52.51%.

Rhelion Life Sciences had a gross margin of 52.51% for the quarter that ended in Mar. 2026 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of Rhelion Life Sciences was 43.22%. The lowest was 17.12%. And the median was 38.31%.


Rhelion Life Sciences  (OTCPK:TRUFF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Rhelion Life Sciences had a gross margin of 52.51% for the quarter that ended in Mar. 2026 => Durable competitive advantage


Rhelion Life Sciences Gross Profit Related Terms


Rhelion Life Sciences Gross Profit Historical Data

* Premium members only.

The historical data trend for Rhelion Life Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhelion Life Sciences Gross Profit Chart

Rhelion Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Gross Profit
Get a 7-Day Free Trial 0.49 1.25 1.49 1.33 1.16

Rhelion Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.33 0.24 0.26 0.34

TRUFF vs ZTS: Gross Profit Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rhelion Life Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhelion Life Sciences Gross Profit vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rhelion Life Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Rhelion Life Sciences's Gross Profit falls into.



Rhelion Life Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Rhelion Life Sciences's Gross Profit for the fiscal year that ended in Mar. 2026 is calculated as

Gross Profit (A: Mar. 2026 )=Revenue - Cost of Goods Sold
=3.058 - 1.898
=1.16

Rhelion Life Sciences's Gross Profit for the quarter that ended in Mar. 2026 is calculated as

Gross Profit (Q: Mar. 2026 )=Revenue - Cost of Goods Sold
=0.638 - 0.303
=0.34

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.16 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Rhelion Life Sciences's Gross Margin % for the quarter that ended in Mar. 2026 is calculated as

Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.34 / 0.638
=52.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $1.16 Mil mean?
Rhelion Life Sciences (TRUFF) has a Gross Profit of $1.16 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Rhelion Life Sciences and its competitors.
Is Rhelion Life Sciences' Gross Profit too high?
Rhelion Life Sciences' current Gross Profit is $1.16 Mil.
How does Rhelion Life Sciences' Gross Profit compare to ZTS?
Rhelion Life Sciences' Gross Profit of $1.16 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Rhelion Life Sciences and its competitors. Rhelion Life Sciences's current Gross Profit is $1.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhelion Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Rhelion Life Sciences (TRUFF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 23.3% above its estimated fair value. The current Gross Profit is $1.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Rhelion Life Sciences (TRUFF), the current Gross Profit is $1.16 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rhelion Life Sciences Business Description

Other Exchanges 4YX:GermanyTRIP:Canada
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Red Light Holland Corp is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands. Its products include Microdosing Kit and Merch. Its revenue is comprised of sales of wholesale truffles, cannabis seeds, and other cannabis products and sales of microdose packs.